(Total Views: 277)
Posted On: 07/11/2023 11:15:47 AM
Post# of 113

$SNGX News Article - Soligenix Announces Expansion of SGX302 (Synthetic Hypericin) Phase 2a Study in Mild-to-Moderate Psoriasis https://marketwirenews.com/news-releases/soli...58519.html


My Twitter: WhyteStocks